MedTrace Logo

Homocysteine and Coronary Artery Disease

NCT06675890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 381

Last updated 2024-11-07

No results posted yet for this study

Summary

This study is aimed at correlating serum homocysteine level with coronary artery disease (CAD) and related in-hospital mortality. A cross section of patients from age 18 years and above will be studied for homocysteine level and analyzed for the above mentioned correlation. The study was approved by hospital ethical review board as mentioned. An informed written consent was obtained before the patients' recruitment.

Conditions

  • Coronary Arterial Disease (CAD)

Interventions

DIAGNOSTIC_TEST

serum homocysteine

serum homocysteine is associated with atherosclerosis and vascular diseases.

Sponsors & Collaborators

  • Shaqra University

    lead OTHER

Principal Investigators

  • Himayat Ullah, FCPS · Shaqra University

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06675890 on ClinicalTrials.gov